Answers are grounded in this paper and cite their sources.
Background and Objectives: Preeclampsia (PE) remains a leading cause of maternal and perinatal morbidity, and reliable non-invasive biomarkers are lacking. The miR-200 family and miR-205-5p regulate the epithelial-to-mesenchymal transition required for trophoblast invasion, making them candidate circulating markers of PE. This study aimed to evaluate plasma levels of these miRNAs and their clinical implication in PE. Materials and Methods: Plasma levels of miR-205-5p, miR-141-3p, miR-200a-3p and miR-200b-3p were measured by qRT-PCR in 47 women with PE (20 non-severe, 27 severe) and 39 women with uncomplicated pregnancies. The clinical significance of each miRNA was evaluated by receiver operating characteristic (ROC) curve analysis. Results: All four miRNAs were significantly downregulated in PE compared with uncomplicated pregnancies. miR-205-5p showed the largest between-group difference (p < 0.001) and the highest diagnostic accuracy (AUC = 0.76), followed by miR-200a-3p (AUC = 0.73), miR-141-3p (AUC = 0.71) and miR-200b-3p (AUC = 0.70). None of the four miRNAs discriminated between non-severe and severe PE. Conclusions: Circulating miR-205-5p and miR-200 family members are reduced in PE, but their individual diagnostic accuracy is modest. Combined-panel and multivariable analyses, correction for multiple comparisons, and external validation are needed before clinical application.
No takes yet. Share an insight, caveat, or question.
Oancea et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: